meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Tuberculosis (TB)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Tuberculosis is an infectious disease that affected more than 50 million people and killed 6.7 million patients alone in the past 5 years. Additionally, the rising incidence of treatment resistance threatens the global effort to eradicate this disease.
Tuberculosis is caused by Mycobacterium tuberculosis. It attacks the lungs and other organs. It is a common infectious disease worldwide. The WHO's 2020 report states that a quarter of the world’s population was infected. About 1.4 million people died of TB. TB is a major public health concern. It needs cost-effective prevention and treatment strategies.
Active tuberculosis (TB) patients typically show symptoms such as persis…
References (Sources)
- A common approach for fighting tuberculosis and leprosy: controlling endoplasmic reticulum stress in myeloid-derived suppressor cells
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- Latent Tuberculosis Infection
- Microbiota and Tuberculosis: A Potential Role of Probiotics, and PostbioticsReview
- Telacebec: an investigational antibacterial for the treatment of tuberculosis (TB)
- Tuberculosis